Successful desensitization after hypersensitivity reaction to cisplatin in a patient with nasopharyngeal carcinoma.
Arisa KinouchiHiroki IshiiKaname SakamotoDaiju SakuraiPublished in: Clinical case reports (2022)
Hypersensitivity reaction to cisplatin can result in discontinuation of chemoradiotherapy in patients with head and neck squamous cell carcinoma. We describe a patient with nasopharyngeal carcinoma who developed cisplatin hypersensitivity and was successfully treated with cisplatin desensitization. Furthermore, it had little impact on the therapeutic performance of cisplatin-combined chemoradiotherapy.